FDA Considers Regulating Homeopathic Remedies
Officials will review data on the safety and evidence behind the alternative therapies in a meeting next month. In the meantime, the Obama administration readies a plan to fight antibiotic-resistant bacteria and the Health and Human Services' inspector general advises labs that waive patient fees because of agreements with doctors that they could be violating anti-kickback statutes.
The Associated Press:
FDA To Scrutinize Unproven Alternative Remedies
Federal officials plan to review the safety and evidence behind alternative remedies like Zicam and Cold-Eeze, products that are protected by federal law, but not accepted by mainstream medicine. The Food and Drug Administration says that it will hold a two-day meeting next month on regulations for homeopathic medicines, which have long occupied a place on the fringes of U.S. health care. Similar to dietary supplements, homeopathic products are not required to prove they are safe or effective before being sold on the market. But unlike supplements, homeopathic medicines state that they are designed to treat specific medical conditions. (Perrone, 3/26)
Politico:
Administration Drafts Plan To Fight Antibiotic-Resistant Bacteria
The Obama administration is about to release a long-awaited plan to fight the spread of antibiotic-resistant bacteria – but scientists and lawmakers are already dismissing it as too weak to make enough progress against one of the most urgent public health risks. (Wheaton and Purdy, 3/26)
Modern Healthcare:
Labs That Waive Patient Fees Risk Kickback Violations, OIG Says
Laboratories that waive some patients' fees as part of agreements with physician practices risk running afoul of the federal anti-kickback statute, HHS' Office of Inspector General said in an advisory opinion Wednesday. The opinion could have implications for how labs charge patients. (Schencker, 3/26)
